HK1178893A1 - 新的苯甲酸吡咯並吡啶衍生物及其用於治療帕金森病的用途 - Google Patents

新的苯甲酸吡咯並吡啶衍生物及其用於治療帕金森病的用途

Info

Publication number
HK1178893A1
HK1178893A1 HK13105757.7A HK13105757A HK1178893A1 HK 1178893 A1 HK1178893 A1 HK 1178893A1 HK 13105757 A HK13105757 A HK 13105757A HK 1178893 A1 HK1178893 A1 HK 1178893A1
Authority
HK
Hong Kong
Prior art keywords
treatment
parkinsons disease
pyrrolopyridine derivatives
new benzoic
benzoic
Prior art date
Application number
HK13105757.7A
Other languages
English (en)
Inventor
Jrme Amaudrut
Benaissa Boubia
Fabrice Guillier
Olivia Poupardin-Olivier
Original Assignee
Inventiva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inventiva filed Critical Inventiva
Publication of HK1178893A1 publication Critical patent/HK1178893A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK13105757.7A 2010-01-08 2013-05-14 新的苯甲酸吡咯並吡啶衍生物及其用於治療帕金森病的用途 HK1178893A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1050113A FR2955110A1 (fr) 2010-01-08 2010-01-08 Nouveaux derives de type pyrrolopyridine benzoique
PCT/FR2011/050023 WO2011083278A1 (fr) 2010-01-08 2011-01-07 Nouveaux derives de type pyrrolopyridine benzoique

Publications (1)

Publication Number Publication Date
HK1178893A1 true HK1178893A1 (zh) 2013-09-19

Family

ID=42124595

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13105757.7A HK1178893A1 (zh) 2010-01-08 2013-05-14 新的苯甲酸吡咯並吡啶衍生物及其用於治療帕金森病的用途

Country Status (22)

Country Link
US (1) US8546385B2 (zh)
EP (1) EP2521727B1 (zh)
JP (1) JP2013516448A (zh)
KR (1) KR20120123042A (zh)
CN (1) CN102753552A (zh)
AR (1) AR079842A1 (zh)
AU (1) AU2011204518A1 (zh)
BR (1) BR112012016844A2 (zh)
CA (1) CA2785876A1 (zh)
DK (1) DK2521727T3 (zh)
EA (1) EA201290601A1 (zh)
ES (1) ES2478191T3 (zh)
FR (1) FR2955110A1 (zh)
HK (1) HK1178893A1 (zh)
MX (1) MX2012007968A (zh)
PL (1) PL2521727T3 (zh)
PT (1) PT2521727E (zh)
SA (1) SA111320080B1 (zh)
TW (1) TWI473806B (zh)
UY (1) UY33166A (zh)
WO (1) WO2011083278A1 (zh)
ZA (1) ZA201204863B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102347368B1 (ko) 2020-11-03 2022-01-07 (주)케이메디켐 신규한 아자인돌 유도체, 이의 제조방법 및 이를 포함하는 인지기능 개선용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9904188A3 (en) 1996-12-13 2003-02-28 Aventis Pharmaceuticals Inc Co Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
DE69942801D1 (de) * 1998-05-26 2010-11-11 Chugai Pharmaceutical Co Ltd Heterozyklische indolderivate und mono- oder diazaindol-derivate
GB0119911D0 (en) 2001-08-15 2001-10-10 Novartis Ag Organic Compounds
GB0303503D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
RU2356889C2 (ru) 2003-07-17 2009-05-27 Плекссикон, Инк. Соединения, являющиеся активными по отношению к рецепторам, активируемым пролифератором пероксисом
WO2005047268A2 (en) 2003-11-10 2005-05-26 X-Ceptor Therapeutics, Inc. Substituted pyrimidine compositions and methods of use
FR2890072A1 (fr) * 2005-09-01 2007-03-02 Fournier S A Sa Lab Nouveaux composesde pyrrolopyridine
FR2903106B1 (fr) 2006-07-03 2010-07-30 Sanofi Aventis Utilisations de 2-benzoyl-imidazopyridines en therapeutique
FR2903105A1 (fr) 2006-07-03 2008-01-04 Sanofi Aventis Sa Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique
FR2903107B1 (fr) 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
US20080200471A1 (en) 2007-02-16 2008-08-21 Memory Pharmaceuticals Corporation 6' substituted compounds having 5-ht6 receptor affinity
US20100022581A1 (en) 2008-07-02 2010-01-28 Memory Pharmaceuticals Corporation Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity

Also Published As

Publication number Publication date
CN102753552A (zh) 2012-10-24
CA2785876A1 (fr) 2011-07-14
JP2013516448A (ja) 2013-05-13
FR2955110A1 (fr) 2011-07-15
BR112012016844A2 (pt) 2018-05-08
US20120302560A1 (en) 2012-11-29
UY33166A (es) 2011-08-31
TWI473806B (zh) 2015-02-21
US8546385B2 (en) 2013-10-01
DK2521727T3 (da) 2014-06-16
WO2011083278A1 (fr) 2011-07-14
ZA201204863B (en) 2013-09-25
AU2011204518A1 (en) 2012-07-26
KR20120123042A (ko) 2012-11-07
EA201290601A1 (ru) 2012-12-28
ES2478191T3 (es) 2014-07-18
SA111320080B1 (ar) 2014-06-23
EP2521727B1 (fr) 2014-03-19
AR079842A1 (es) 2012-02-22
PL2521727T3 (pl) 2014-08-29
MX2012007968A (es) 2012-08-03
TW201144307A (en) 2011-12-16
EP2521727A1 (fr) 2012-11-14
PT2521727E (pt) 2014-06-25

Similar Documents

Publication Publication Date Title
EP2542086A4 (en) COMPOUNDS AND ITS THERAPEUTIC USE
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
HK1184370A1 (zh) 用於治療疼痛的藥物組合
IL223286A0 (en) Piperidine derivatives and their use for the treatment of metabolic disorders
GB201004020D0 (en) New therapeutic use
IL218137A0 (en) Therapeutic aryl-amido-aryl compounds and their use
HK1176936A1 (en) Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof
IL223721A0 (en) Heterocyclic compounds, their preparation and their therapeutic application
IL260078B (en) Therapy used to treat Gaucher disease
GB201011411D0 (en) Therapeutic compounds and their use
HK1184779A1 (zh) 新型化合物和其醫藥用途
IL234093A0 (en) Preparations and dosages for oral administration and their uses for the treatment of Gaucher's disease
PT2555790T (pt) USO TERAPÊUTICO DA PROTEÍNA DE ß MICROGLOBULINA
HUP1000343A2 (en) Use of kynurenic acid amide derivatives for the treatment of huntington disease
HK1214771A1 (zh) 用於治療皮膚病的製劑
HK1178893A1 (zh) 新的苯甲酸吡咯並吡啶衍生物及其用於治療帕金森病的用途
HK1188565A1 (zh) 二芳基噠嗪酮衍生物、其製備方法及其用於人類治療的用途
GB201001383D0 (en) New compounds and medical uses
GB201001376D0 (en) New compounds and medical uses
GB201001370D0 (en) New compounds and medical uses
GB201001364D0 (en) New compounds and medical uses
GB0913300D0 (en) Therapeutic compounds and their use
GB201004479D0 (en) Therapeutic use of new compounds I
GB201018362D0 (en) Treatment of dupuytren's disease
GB201004480D0 (en) Therapeutic use of new compounds II

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180107